Trelagliptin succinate
Product Specifications
Target
DPP-4|||Proteasome
Related Pathways
Proteases/Proteasome|||Ubiquitination
Purity
>99.99%
Bioactivity
Trelagliptin succinate (SYR-472 succinate) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D) .
Smiles
Cn1c(=O)cc(n(c1=O)Cc1c(ccc(c1)F)C#N)N1CCC[C@H](C1)N.C(CC(=O)O)C(=O)O
Molecular Formula
C22H26FN5O6
Molecular Weight
475.47
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/37F67795-A18F-4549-8275-193E02D8E9E5/T2296
CAS Number
1029877-94-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6200378-01 0.1 mL
CYP2D6 (Debrisoquine 4-hydroxylase, Cytochrome P450-DB1, CYPIID6, Cytochrome P450 2D6, CYP2DL1) (MaxLight 490)
Ask
View Details 
MBS6200378-02 5x 0.1 mL
CYP2D6 (Debrisoquine 4-hydroxylase, Cytochrome P450-DB1, CYPIID6, Cytochrome P450 2D6, CYP2DL1) (MaxLight 490)
Ask
View Details